Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innoway R&D Kft. is a patent-focused academic spin-out company based in Budapest, Hungary, that operates at the intersection of clinical need, engineering, and translational research. Founded by a multidisciplinary team of medical doctors, engineers, and scientists, the company designs innovative medical devices, digital health applications, and novel treatment approaches. Its diverse portfolio includes the "Mechanical Retractor" for brain surgery, the "NeuroSpot" ventriculostomy entry point software, the "Initus-V 222" Far-UVC air and surface disinfection system, and "Policapr," a mobile device for producing personalized polypills. Additionally, Innoway R&D is developing "GLIOMIR," an autologous natural killer (NK) cell therapy for glioblastoma multiforme and anaplastic astrocytomas, and "Curatio Dualis," a transfemorally implanted aortic stent system for neuromodulation in resistant hypertension.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innoway R&D.